A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06256588 · RECRUITING

Trial details

NCT number: NCT06256588
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Head and Neck

Start date: 2024-03-21
Primary completion: 2028-06-30
Enrollment: 864

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.